The global Microfluidics Devices Market size has shown notable growth, reaching USD 7.62 billion in 2024. It is expected to rise to USD 16.20 billion by 2033, growing at a CAGR of 6.9% from 2025 to 2033The Microfluidics Devices Market is growing because of the rising demand for fast, accurate, and affordable diagnostics, particularly in point-of-care testing. Improvements in lab-on-a-chip...

The global Microfluidics Devices Market size has shown notable growth, reaching USD 7.62 billion in 2024. It is expected to rise to USD 16.20 billion by 2033, growing at a CAGR of 6.9% from 2025 to 2033The Microfluidics Devices Market is growing because of the rising demand for fast, accurate, and affordable diagnostics, particularly in point-of-care testing. Improvements in lab-on-a-chip...

Unlocking Future Potential: In-Depth Analysis of the Microfluidics Market by Maximize Market Research Maximize Market Research (MMR), a premier business consultancy firm, proudly announces the release of its latest market analysis on the Microfluidics Market. This extensive report offers comprehensive insights, from pricing trends and demand fluctuations to key...

The Microfluidics Market size was valued at USD 33.75 Billion in 2024 and the total Microfluidics revenue is expected to grow at a CAGR of 17.2% from 2025 to 2032, reaching nearly USD 120.17 Billion. Microfluidics Market Overview: Maximize Market Research is a Business Consultancy Firm that has published a detailed analysis of the “Microfluidics Market”. The report...

The Microfluidics Market size was valued at USD 33.75 Billion in 2024 and the total Microfluidics revenue is expected to grow at a CAGR of 17.2% from 2025 to 2032, reaching nearly USD 120.17 Billion. Microfluidics Market Overview: Maximize Market Research is a Business Consultancy Firm that has published a detailed analysis of the “Microfluidics Market”. The report...

According to a new report by Polaris Market Research, the global microfluidics company market was valued at USD 33.41 billion in 2023 and is projected to reach USD 86.23 billion by 2032, expanding at a CAGR of 11.1% over the forecast period. Growth is underpinned by rising point-of-care diagnostics adoption, expanding lab-on-a-chip innovation, and accelerating organ-on-a-chip research...